Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
222 participants
INTERVENTIONAL
2016-07-19
2017-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Topical Antifungal Treatment for Tinea Pedis
NCT01396811
Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis
NCT02842021
Topical Antifungal Treatment for Tinea Pedis
NCT01396785
A Dose Response Trial to Evaluate Clinical and Mycological Effect of Nitric Oxide in Subjects With Tinea Pedis
NCT00893880
A Trial to Evaluate the Safety and and Tolerability of DBI-001 in Patients With Tinea Pedis
NCT04152226
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SB208 2%
Apply once daily to one or both feet for 14 days
SB208 2%
Apply once daily to one or both feet for 14 days
SB208 4%
Apply once daily to one or both feet for 14 days
SB208 4%
Apply once daily to one or both feet for 14 days
SB208 16%
Apply once daily to one or both feet for 14 days
SB208 16%
Apply once daily to one or both feet for 14 days
Vehicle Gel
Apply once daily to one or both feet for 14 days
Vehicle Gel
Apply once daily to one or both feet for 14 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SB208 2%
Apply once daily to one or both feet for 14 days
SB208 4%
Apply once daily to one or both feet for 14 days
SB208 16%
Apply once daily to one or both feet for 14 days
Vehicle Gel
Apply once daily to one or both feet for 14 days
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* T.pedis provisionally confirmed at baseline by a positive KOH wet mount for segmented fungal hyphae on skin scraping from the target site
Exclusion Criteria
* Subjects with onychomycosis or moccasin-type t. pedis
* Subjects using topical or systemic anti-fungal agents
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novan, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
M Joyce Rico, MD
Role: STUDY_DIRECTOR
Novan, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Instituto Dermatológico y Cirugía de Piel,
Santo Domingo, , Dominican Republic
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NI-AF201
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.